Categories
Health Law Highlights

Tame The Private Equity Beast By Shifting Its Focus To Value-Based Care

Summary of article from Health Affairs, by Ken Terry:

The influence of private equity (PE) firms on the healthcare industry has lead to several concerns, including reduced quality of patient care, increased expenses, and potential economic instability. However, PE firms could also play a constructive role in healthcare reform if their investments were directed towards helping entities transition to value-based care (VBC). Tax incentives could motivate PE investments in VBC-oriented entities (VOEs). Policy changes, such as extending holding periods for health assets, creating escrow accounts for failed strategies, and establishing joint liability between PE firms and their owned companies, could motivate PE firms to focus on primary care and reduce healthcare waste.

Categories
Health Law Highlights

Honest Services Fraud: A World Beyond the Anti-Kickback Statute

Summary of article from Dorsey & Whitney LLP, by Nicole Engisch, Seth Goertz, Sarah Malham, Mara Sanders:

The Department of Justice (DOJ) is increasingly using Honest Services Fraud (18 U.S.C. § 1346) to prosecute bribery, kickbacks, and other improper payments in the healthcare industry, in addition to traditional mechanisms like the Anti-Kickback Statute and the Federal False Claims Act. The honest services fraud law is especially useful as it covers areas not reached by the Anti-Kickback Statute, which is limited to federally funded healthcare programs. Recent court cases have upheld convictions based on honest services fraud, indicating its growing relevance in combating healthcare fraud. Therefore, it is crucial for healthcare practitioners and administrators to carefully review payment arrangements and financial interests that intersect with patient service delivery, ensuring full disclosure of relevant financial interests.

Categories
Alert

Local Physician and Practice Agree to Pay Over $2 Million to Settle False Claims Act Allegations

Press Release from U.S. Attorney’s Office, Eastern District of Michigan:

I don’t normally report on False Claims Act (FCA) matters from other states, but this one serves as a cautionary tale on “incident to” billing.

Under Medicare rules, covered services provided by non-physician practitioners (NPPs), like physician assistants, nurse practitioners, clinical nurse specialists, etc., are reimbursed at a reduced rate of 85 percent of the fee schedule amount.

The “incident-to” billing rules provide an exception, allowing 100 percent reimbursement for NPP services that meet the requirements detailed in the Medicare Benefit Policy Manual, Chapter 15, Section 60 (Services and Supplies Furnished Incident To a Physician’s/NPP’s Professional Service).

Among other requirements, to bill a NPPs services as “incident to” the physician’s initial evaluation, the physician must provide direct supervision. Without direct supervision, the NPPs services must be billed under the NPPs provider number at the reduced rate.

Direct supervision in the office setting does not mean that the physician must be present in the same room, but the physician must be present in the office suite and immediately available to provide assistance and direction throughout the time the aide is performing services.

Direct supervision in the home health setting, requires the physician to be physically present in the home to oversee the care.

In this reported FCA settlement, the NPP’s home health services were being billed “incident to” the physician’s services, but the physician was not physicially present in the home. Thus, the physican and his practice falsely claimed an extra 15% reimbursement on all those services.

The physician and his practice paid $2,003,800.91 to resolve the FCA allegations.

The moral of the story … know the rules about billing, and if you don’t, hire someone who does.

Categories
Health Law Highlights

Is Your Compliance House In Order? Tips for Ensuring Private Equity and Portfolio Company Compliance

Summary of article from Bass, Berry & Sims PLC, by Angela Humphreys, Jennifer Michael:

The recent Request for Information by federal agencies highlights the need for private equity (PE) firms to have robust compliance programs for their healthcare sector investments. Such programs should align with the Office of Inspector General’s General Compliance Program Guidance, and include written policies, procedures, risk analyses, and audits. PE firms need to understand their role and risk profile in the portfolio company’s structure, including their involvement in executive hiring, business program implementation, and potential antitrust issues. Equity incentive awards should comply with both the Stark Law and the federal Anti-Kickback Statute. Lastly, PE firms should ensure attorney-client privilege is maintained in their interactions with both the portfolio company and outside counsel.

Categories
Health Law Highlights

Navigating Tax Due Diligence in Healthcare Acquisitions

Summary of article from VMG Health, by Grayson Terrell, CPA; Joe Scott, CPA; Lukas Recio, CPA; Wayne Prior, CPA; and the Baker Tilly team:

Healthcare M&A transactions require a collaborative approach between financial and tax due diligence experts to identify potential problems and their tax consequences, which can impact the deal structure and negotiation process. Tax considerations, such as whether a sale is taxable or tax-free, greatly influence the structure of a sale. The tax entity type of the target (S corporation, Partnership, or C corporation) is crucial to understand as it affects the arising tax issues. Common healthcare tax due diligence issues include improper independent contractor classification, unclaimed property, improper treatment of owner personal expenses, unreasonable owner compensation, related-party transactions, cash vs. accrual accounting method, pass-through entity tax, 20 percent deduction under Section 199A, built-in gains tax, and non-resident withholding. Each of these issues requires careful consideration and vetting to avoid potential adverse tax implications for the buyer.

Categories
Health Law Highlights

Some Nurses Have a Deep Distrust of AI – but Transparency and Training Could Help

Summary of article from Healthcare IT News, by Andrea Fox:

The California Nurses Association (CNA) has protested against the use of artificial intelligence (AI) in healthcare by Kaiser Permanente, citing concerns over patient safety, job displacement, and the devaluation of nursing practice. The CNA demands that workers and unions be involved in the development and deployment of AI in healthcare. Meanwhile, Kaiser Permanente argues that AI can improve patient care, citing a program that reportedly saved approximately 500 patient lives annually. A recent report revealed that many nurses are uncomfortable with AI, with concerns ranging from lack of empathy to data security. The report suggests that for successful AI implementation, healthcare organizations should prioritize transparency, training, communication, and feedback.

Categories
Health Law Highlights

What Parkland Can Teach Other Hospitals About AI in Health Care

Summary of article from Dallas Morning News:

Parkland Health is actively utilizing artificial intelligence (AI) in medical practices, including trauma patient treatment and assisting doctors with paperwork. The technology analyzes patient data and updates survival probabilities in real time, while also transcribing doctors’ notes. Despite potential AI biases and inaccuracies, Parkland mitigates these risks through regular model reviews. The hospital, an early adopter of electronic health records and a member of Duke University’s Health AI partnership corps, has leveraged AI to predict patient needs and manage patient loads. Being a public hospital, Parkland strategically implements thoroughly vetted AI tools or collaborates with the Parkland Center for Clinical Innovation on new technologies.

Categories
Health Law Highlights

FDA Finalizes Rule Regulating Laboratory Developed Tests

Summary of article from Polsinelli, by Suzanne Bassett, Michael Gaba:

The FDA’s Final Rule regulating Laboratory-Developed Tests (LDTs) was published on May 6, 2024, and is expected to take effect in 60 days. The rule expands the definition of in vitro diagnostics (IVDs) to include LDTs and will significantly alter the regulatory landscape for LDTs, impacting manufacturers, patients, and healthcare providers. Despite over 6,500 comments, no substantial changes were made from the Proposed Rule to the Final Rule, but there were significant adjustments to enforcement discretion policies. The rule is expected to face legal challenges and potential legislative action from Congress. The Final Rule applies to all IVDs offered as LDTs, regardless of whether the test meets the traditional definition.

Categories
Health Law Highlights

How HHS OCR Is Boosting HIPAA Enforcement; Here Come Audits

Summary of article from BankInfo Security, by Marianne Kolbasuk McGee:

The Department of Health and Human Services (HHS) is working on a proposed update to the HIPAA Security Rule and intensifying enforcement efforts, including resuming HITECH Act HIPAA audits. The focus is on the requirement for risk analysis, a significant weakness among regulated organizations, contributing to many breaches. HHS plans to update the HIPAA Security Rule by the end of the year to reflect technological and healthcare delivery changes over the last two decades. Despite its scalability and technology-neutral nature, the rule’s 20-year-old framework doesn’t reflect current healthcare practices, necessitating the integration of practices like end-to-end encryption. Additionally, the HHS has reopened HITECH audits and is proactively conducting them.

Categories
Health Law Highlights

Do Cosmetic Injections Involve The Practice Of Medicine?

Summary of article from Hendershot & Cowart, by Keith Lefkowitz:

Cosmetic injections, such as Botox and dermal fillers, are considered the practice of medicine in Texas and can only be performed under the authority of a physician. Texas law has seen a series of criminal cases involving unlicensed practice of medicine and cosmetic injections, resulting in serious consequences. Practicing medicine without a license is a crime in Texas, with penalties ranging from state jail felonies to third degree felonies, depending on the harm caused. The Texas Medical Board and Attorney General can also impose civil penalties and issue cease-and-desist orders. Therefore, healthcare providers and med spa owners are advised to consult with a healthcare attorney to ensure regulatory compliance and patient safety.